Clinical Trial Update: Crestor RAPID (The Efficacy of RosuvAstatin for Korean Dyslipidemia PatIents With Diabetes)

View source ↗

Summary

A completed clinical trial evaluating the efficacy of rosuvastatin (Crestor) in Korean patients with dyslipidemia and diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Dyslipidemia

Drugs mentioned

• CRESTOR (Rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidemia, Diabetes | Status: COMPLETED